ARCHIVES

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

This article is from The Cancer Letter archive.

Vol. 20 No. 46 | December 2, 1994

Download PDF Visit The Full Archive

Related Articles

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License

November 10, 1995

Cancer Training Programs Fairing Fairley Well

December 1, 1989

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000